Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-745bb68f8f-l4dxg Total loading time: 0 Render date: 2025-02-01T00:06:36.312Z Has data issue: false hasContentIssue false

Chapter 7 - Immunophenotyping of Mature B-Cell Lymphomas

Published online by Cambridge University Press:  30 January 2025

By
Olof Axler  and
Anna Porwit
Edited by
Anna Porwit  and
Marie Christine Béné
Anna Porwit
Affiliation:
Lunds Universitet, Sweden
Marie Christine Béné
Affiliation:
Université de Nantes, France
Get access

Summary

This chapter provides useful guidelines for the immunophenotypic identification of both indolent and aggressive B-cell lymphomas. An integrated diagnostics is necessary to provide the final classification, but flow cytometry allows for a quick orientation about the lymphoma subtype and may help in speeding targeted further assays and therapeutic decisions.

Keywords

flow cytometryimmunophenotypingB-lineagelymphomachronic lymphocytic leukemiaclassificationstagingmonotypypre-analyticspanels
Type
Chapter
Information
Multiparameter Flow Cytometry in the Diagnosis of Hematologic Malignancies , pp. 108 - 126
Publisher: Cambridge University Press
Print publication year: 2025

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Tanqri, S, Vall, H, Kaplan, D, et al. Validation of cell based fluorescence assays: practice guidelines from the ICSH and ICCS part III analytical issues. Cytometry B, Clin Cytom 2013; 84: 291–308.CrossRefGoogle Scholar
Johansson, U, Bloxham, D, Couzens, S, et al. Guidelines on the use of multicolour flow cytometry in the diagnosis of haematological neoplasms. British Committee for Standards in Haematology. Brit J Haem 2014; 165: 455–488.CrossRefGoogle ScholarPubMed
van Dongen, JJ, Lhermitte, L, Bottcher, S, et al. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 2012; 26: 1908–1975.CrossRefGoogle ScholarPubMed
Rajab, A and Porwit, A. Screening bone marrow samples for abnormal lymphoid populations and myelodysplasia-related features with one 10-color 14-antibody screening tube. Cytometry B, Clin Cytom 2015; 88: 253–260.CrossRefGoogle ScholarPubMed
Rajab, A, Axler, O, Leung, J, et al. Ten-color 15-antibody flow cytometry panel for immunophenotyping of lymphocyte population. Int J Lab Hemat 2017; 39 Suppl 1: 76–85.CrossRefGoogle ScholarPubMed
Wood, BL, Arroz, M, Barnett, D, et al. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry B, Clin Cytom 2007; 72 Suppl 1: S14–S22.CrossRefGoogle ScholarPubMed
Béné, MC Nebe T, Bettelheim, P, et al. Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia 2011; 25: 567–574.CrossRefGoogle ScholarPubMed
Böttcher, S, Engelmann, R, Grigore, G, et al. Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study. Blood Adv 2022; 6: 976–992.CrossRefGoogle ScholarPubMed
Hedley, BD, Keeney, M, Popma, J, et al. Novel lymphocyte screening tube using dried monoclonal antibody reagents. Cytometry B, Clin Cytom 2015; 88: 361–370.CrossRefGoogle ScholarPubMed
Espasa, A, Torrents, S, Morales-Indiano, C et al., Diagnostic performance of the ClearLLab 10C B cell tube. Cytometry B Clin Cytom 2021; 100: 519–530.CrossRefGoogle ScholarPubMed
Swerdlow, SH, Campo, E, Pileri, SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127: 2375–2390.CrossRefGoogle ScholarPubMed
Juliusson, G, Oscier, DG, Fitchett, M, et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. New Eng J Med 1990; 323: 720–724.CrossRefGoogle ScholarPubMed
Stilgenbauer, S, Bullinger, L, Lichter, P, et al. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course. Leukemia 2002; 16: 993–1007.CrossRefGoogle ScholarPubMed
Landgren, O, Albitar, M, Ma, W, et al. B-cell clones as early markers for chronic lymphocytic leukemia. New Eng J Med 2009; 360: 659–667.CrossRefGoogle Scholar
Strati, P, Shanafelt, TD. Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification. Blood 2015; 126: 454–462.CrossRefGoogle ScholarPubMed
Rawstron, AC, Kreuzer, KA, Soosapilla, A, et al. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: an European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project. Cytometry B Clin Cytom. 2018; 94: 121–128.CrossRefGoogle ScholarPubMed
Quijano, S, Lopez, A, Rasillo, A, et al. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia. Cytometry B, Clin Cytom 2008; 74: 139–149.CrossRefGoogle Scholar
Tomomatsu, J, Isobe, Y, Oshimi, K, et al. Chronic lymphocytic leukemia in a Japanese population: varied immunophenotypic profile, distinctive usage of frequently mutated IGH gene, and indolent clinical behavior. Leuk Lymph 2010; 51: 2230–2239.CrossRefGoogle Scholar
Mason, EF, Pozdnyakova, O, Li, B, et al. Flow cytometric patterns of CD200 and CD1d expression distinguish CD10-negative, CD5-negative mature B-cell lymphoproliferative disorders. Am J Clin Path 2017; 148: 33–41.CrossRefGoogle ScholarPubMed
Couillez, G, Morel, P, Clichet, V, et al. Flow cytometry as a fast, cost-effective tool to assess IGHV mutational status in CLL. Blood Adv 2023; 7: 4701–4704.CrossRefGoogle ScholarPubMed
Rawstron, AC, Fazi, C, Agathangelidis, A, et al. A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study. Leukemia 2016; 30: 929–936.CrossRefGoogle Scholar
Alaggio, R, Amador, C, Anagnostopoulos, I et al. The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 2022; 36: 1720–1748.CrossRefGoogle ScholarPubMed
Campo, E, Jaffe, ES, Cook, JR, et al. The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee. Blood 2022; 140: 1229–1253.CrossRefGoogle ScholarPubMed
Porwit, A, Fend, F, Kremer, M, et al. Issues in diagnosis of small B cell lymphoid neoplasms involving the bone marrow and peripheral blood. Report on the Bone Marrow Workshop of the XVIIth meeting of the European Association for Haematopathology and the Society for Hematopathology. Histopathology 2016; 69: 349–373.CrossRefGoogle Scholar
Demurtas, A, Stacchini, A, Aliberti, S, et al. Tissue flow cytometry immunophenotyping in the diagnosis and classification of non-Hodgkin’s lymphomas: a retrospective evaluation of 1,792 cases. Cytometry B, Clin Cytom 2013;84: 82–95.CrossRefGoogle ScholarPubMed
Favre, R, Manzoni, D, Traverse-Glehen, A, et al. Usefulness of CD200 in the differential diagnosis of SDRPL, SMZL, and HCL. Int J Lab Hem 2018; 40: e59–e62.CrossRefGoogle ScholarPubMed
Julhakyan, L, Al-Radi, LS, Moiseeva, TN, et al. A single-center experience in splenic diffuse red pulp lymphoma siagnosis. Clin Lymph, Myeloma Leuk 2016; 16 Suppl: S166–S169.CrossRefGoogle Scholar
Chen, YS, Tallman, MS. Goolsby, C, et al. Immunophenotypic variations in hairy cell leukemia. Am J Clin Path 2006; 125: 251–259.CrossRefGoogle ScholarPubMed
Garnache Ottou, F, Chandesris, MO, Lhermitte, L, et al. Peripheral blood 8 colour flow cytometry monitoring of hairy cell leukaemia allows detection of high-risk patients. Br J Haematol 2014; 166: 50–59.CrossRefGoogle ScholarPubMed
Robak, T, Robak, P. Measurable residual disease in hairy cell leukemia: technical considerations and clinical significance. Front Oncol 2022; 12: 976374.CrossRefGoogle ScholarPubMed
Paillassa, J, Safa, F, Troussard, X. Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib. Ther Adv Hematol 2022; 13: 20406207221090886.CrossRefGoogle ScholarPubMed
Salem, DA, Scott, D, McCoy, CS, et al. Differential expression of CD43, CD81, and CD200 in classic versus variant hairy cell leukemia. Cytometry B Clin Cytom 2019; 96B: 275–282.CrossRefGoogle Scholar
Paiva, B, Montes, MC, Garcia-Sanz, R, et al. Multiparameter flow cytometry for the identification of the Waldenstrom’s clone in IgM-MGUS and Waldenstrom’s macroglobulinemia: new criteria for differential diagnosis and risk stratification. Leukemia 2014; 28: 166–173.CrossRefGoogle ScholarPubMed
Raimbault, AS, Machherndl-Spandl, S, Itzykson, R, et al. CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation. Br J Haematol 2019; 184: 625–633.CrossRefGoogle Scholar
Lianqun, Q, Okechukwu, V, Nwogbo, L, et al. Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms. Hum Pathol 2022, 130, 47–57.Google Scholar
Owen, RG, Kyle, RA, Stone, RJ, et al. Response assessment in Waldenstrom macroglobulinaemia: update from the VIth International Workshop. Br J Haemat 2013; 160: 171–176.CrossRefGoogle ScholarPubMed
Xiong, W, Wang, Z, Wang, T, et al. Minimal residual disease status improved the response evaluation in patients with Waldenström’s macroglobulinemia. Front Immunol 2023; 14: 1171539.CrossRefGoogle ScholarPubMed
Mantei, K, Wood, BL. Flow cytometric evaluation of CD38 expression assists in distinguishing follicular hyperplasia from follicular lymphoma. Cytometry B, Clin Cytom 2009; 76: 315–320.CrossRefGoogle ScholarPubMed
Laane, E, Tani, E, Bjorklund, E, et al. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin’s lymphoma. Cytometry B, Clin Cytom 2005; 64: 34–42.CrossRefGoogle ScholarPubMed
Wu, JM, Borowitz, MJ, Weir, EG. The usefulness of CD71 expression by flow cytometry for differentiating indolent from aggressive CD10+ B-cell lymphomas. Am J Clin Path 2006; 126: 39–46.CrossRefGoogle ScholarPubMed
Gao, J, Peterson, L, Nelson, B, et al. Immunophenotypic variations in mantle cell lymphoma. Am J Clin Pathol 2009; 132: 699–706.CrossRefGoogle ScholarPubMed
Annapurna Saksena, C, Cameron, Y, Jie, X, et al. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis, Hum Pathol 2019; 89: 71–80.CrossRefGoogle Scholar
Medd, PG, Clark, N, Leyden, K, et al. A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma. Cytometry B, Clin Cytom 2011; 80: 230–237.CrossRefGoogle Scholar
Wasik, AM, Priebe, V, Lord, M, et al. Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma from mantle cell lymphoma. Leuk Lymph 2015; 56: 1425–1431.CrossRefGoogle ScholarPubMed
Cheminant, M, Derrieux, C, Touzart, A, et al. Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study. Haematologica 2016; 101: 336–345.CrossRefGoogle ScholarPubMed
Zhou, Y, Chen, H, Tao, Y, Zhong, Q, Shi, Y. Minimal residual disease and survival outcomes in patients with mantle cell lymphoma: a systematic review and meta-analysis. J Cancer 2021; 12: 553–556.CrossRefGoogle ScholarPubMed
Alonso-Álvarez, S, Alcoceba, M, García-Álvarez, M, et al. Biological features and prognostic impact of bone marrow infiltration in patients with diffuse large B-cell lymphoma. Cancers 2020; 12: 474.CrossRefGoogle ScholarPubMed
Hiraga, J, Tomita, A, Sugimoto, T, et al. Downregulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance. Blood 2009; 113: 4885–4893.CrossRefGoogle ScholarPubMed
Durani, U, Ansell, SM. CD5+ diffuse large B-cell lymphoma: a narrative review. Leuk Lymphoma. 2021; 62: 3078–3086.CrossRefGoogle ScholarPubMed
Suzuki, Y, Yoshida, T, Wang, G, et al. Incidence and clinical significance of aberrant T-cell marker expression on diffuse large B-cell lymphoma cells. Acta Haematol 2013; 130: 230–237.CrossRefGoogle ScholarPubMed
McGowan, P, Nelles, N, Wimmer, J, et al. Differentiating between Burkitt lymphoma and CD10+ diffuse large B-cell lymphoma: the role of commonly used flow cytometry cell markers and the application of a multiparameter scoring system. Am J Clin Path 2012; 137: 665–670.CrossRefGoogle ScholarPubMed
Mandelker, DL, Dorfman, DM, Li, B, et al. Antigen expression patterns of MYC-rearranged versus non-MYC-rearranged B-cell lymphomas by flow cytometry. Leuk Lymphoma 2014; 55: 2592–2596.CrossRefGoogle ScholarPubMed
Alsuwaidan, A, Pirruccello, E, Jaso, J, et al. Bright CD38 expression by flow cytometric analysis is a biomarker for double/triple hit lymphomas with a moderate sensitivity and high specificity. Cytometry B Clin Cytom 2019; 96B: 368–374.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×